{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:07:20Z","timestamp":1774980440728,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.urolonc.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T19:50:56Z","timestamp":1314301856000},"page":"930-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["JAK3 in clear cell renal cell carcinoma: Mutational screening and clinical implications"],"prefix":"10.1016","volume":"31","author":[{"given":"Michela","family":"de Martino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia","family":"Prattichizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ariano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe S.","family":"Netti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eustacchio","family":"Montemurno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2011.07.001_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ucl.2008.07.006","article-title":"Molecular biology of renal cortical tumors","volume":"35","author":"Klatte","year":"2008","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2011.07.001_bib2","article-title":"RET protein expression in papillary renal cell carcinoma","author":"Flavin","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib3","article-title":"Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells","author":"Lai","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urolonc.2008.08.006","article-title":"Hypoxia inducible factor (HIF): Its central role in renal cell cancer targeted therapy","volume":"27","author":"Loughlin","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.urolonc.2007.12.001","article-title":"Clinical implications of hypoxia inducible factor in renal cell carcinoma","volume":"27","author":"Smaldone","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.juro.2009.11.032","article-title":"Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene","volume":"183","author":"de Martino","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.urology.2010.11.033","article-title":"Insertion\/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma","volume":"77","author":"de Martino","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.07.001_bib8","article-title":"GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer","author":"Salinas-Sanch\u00e9z","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.juro.2009.03.077","article-title":"CA9 gene: Single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis","volume":"182","author":"de Martino","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ncponc0926","article-title":"Interleukin 2 for patients with renal cancer","volume":"4","author":"Rosenberg","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib11","series-title":"Cytokines, Cellular, and molecular immunology","first-page":"260","author":"Abbas","year":"2003"},{"key":"10.1016\/j.urolonc.2011.07.001_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.urolonc.2011.07.001_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"JAKS and STATs: Biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1023805715476","article-title":"JAK family of kinases in cancer","volume":"22","author":"Verma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.urolonc.2011.07.001_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-2896.2005.00220.x","article-title":"JAK3, severe combined immunodeficiency, and a new class of immunosuppressive drugs","volume":"203","author":"Pesu","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.urolonc.2011.07.001_bib16","doi-asserted-by":"crossref","first-page":"25378","DOI":"10.1074\/jbc.M011363200","article-title":"Cytokine-independent JAK3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex","volume":"276","author":"Tomita","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2011.07.001_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0955-0674(97)80067-1","article-title":"The state of the STATs: Recent developments in the study of signal transduction to the nucleus","volume":"9","author":"Horvath","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/370153a0","article-title":"Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells","volume":"370","author":"Witthuhn","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2011.07.001_bib19","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-07-4839","article-title":"Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers","volume":"14","author":"Jeong","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2011.07.001_bib20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/sj.leu.2404527","article-title":"JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults","volume":"21","author":"Kiyoi","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.urolonc.2011.07.001_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.molimm.2004.04.014","article-title":"JAK3 and the pathogenesis of severe combined immunodeficiency","volume":"41","author":"O'Shea","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","article-title":"Therapeutic targeting of Janus kinases","volume":"223","author":"Pesu","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.urolonc.2011.07.001_bib23","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.159.6.3057","article-title":"Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: Role of soluble products from human renal cell carcinomas","volume":"159","author":"Kolenko","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib24","series-title":"Tumours of the Kidney, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","first-page":"9","author":"Eble","year":"2004"},{"key":"10.1016\/j.urolonc.2011.07.001_bib25","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1093\/emboj\/19.17.4449","article-title":"Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain","volume":"19","author":"Hamada","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.urolonc.2011.07.001_bib26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(01)00398-7","article-title":"Unexpected effects of FERM domain mutations on catalytic activity of JAK3: Structural implication for Janus kinases","volume":"8","author":"Zhou","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.urolonc.2011.07.001_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004399900200","article-title":"Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism","volume":"106","author":"Schumacher","year":"2000","journal-title":"Hum Genet"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2011.07.001_bib28","first-page":"S81","article-title":"Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: A mechanism of immune escape","volume":"6","author":"Rayman","year":"2000","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.urolonc.2011.07.001_bib29","doi-asserted-by":"crossref","first-page":"F1836","DOI":"10.1152\/ajprenal.00096.2007","article-title":"JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism","volume":"293","author":"Wu","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.urolonc.2011.07.001_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/935764","article-title":"JAK3\/STAT5\/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients","volume":"2010","author":"Cavalcanti","year":"2010","journal-title":"J Biomed Biotechnol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911002213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911002213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:35Z","timestamp":1761040895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911002213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1078143911002213"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.07.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK3 in clear cell renal cell carcinoma: Mutational screening and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}